


The Fund aims to provide a combination of income and long term capital growth.
| Name | % Net Assets | 
|---|---|
| HSBC Holdings | 8.8% | 
| Royal Dutch Shell | 7.0% | 
| BP | 6.8% | 
| Glaxosmithkline | 6.8% | 
| Travis Perkins | 5.1% | 
| Vodafone Group | 4.6% | 
| Astrazeneca | 4.3% | 
| UNILEVER | 4.1% | 
| SIGNET JEWELERS LTD | 3.8% | 
| British American Tobacco | 2.9% | 
| Key | % Net Assets | 
|---|---|
| 8.8% | |
| 7.0% | |
| 6.8% | |
| 6.8% | |
| 70.6% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 807.06p | 
| Currency | GBP | 
| Change | -1.26p | 
| % | -0.16% | 
| YTD change | 142.31p | 
| YTD % | 21.41% | 
| Fund Inception | 02/10/1978 | 
|---|---|
| Fund Manager | Alastair Mundy | 
| TER | 1.60 (30-Sep-2011) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £100 | 
| Savings | £100 | 
| Charges | |
|---|---|
| Initial | 4.50% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.17 | 
You are here: research